Allison Hall
Overview
Explore the profile of Allison Hall including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
617
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Marks J, Zhang D, Hardman T, Chen Y, Hall A, Simpson L, et al.
Breast Cancer Res
. 2025 Feb;
27(1):26.
PMID: 39980051
Purpose: CALGB 40903 (Alliance) was a phase II single arm multicenter trial conducted in postmenopausal patients diagnosed with estrogen-receptor (ER) positive breast ductal carcinoma in situ (DCIS) without invasion. Patients...
2.
Kumar S, Al-Ogaili A, Hall A, Azzalini L, Alaswad K, Rinfret S, et al.
J Invasive Cardiol
. 2024 Nov;
PMID: 39565942
Prevention, prompt diagnosis, and rapid treatment are crucial for improving outcomes of complications that occur during percutaneous coronary intervention (PCI). The authors summarize studies on PCI complications published between January...
3.
Qin X, Strand S, Lee M, Saraswathibhatla A, van IJzendoorn D, Zhu C, et al.
bioRxiv
. 2024 Oct;
PMID: 39386437
Significance: Single cell analysis reveals that preinvasive breast cancer is comprised of multiple genetic clones and there is substantial phenotypic diversity both within and between these clones. Ductal carcinoma in...
4.
Fortunato A, Mallo D, Cisneros L, King L, Khan A, Curtis C, et al.
medRxiv
. 2024 Aug;
PMID: 39185534
Progression from pre-cancers like ductal carcinoma (DCIS) to invasive disease (cancer) is driven by somatic evolution and is altered by clinical interventions. We hypothesized that genetic and/or phenotypic intra-tumor heterogeneity...
5.
Rempakos A, Alexandrou M, Simsek B, Kostantinis S, Karacsonyi J, Mutlu D, et al.
J Invasive Cardiol
. 2024 Jul;
36(11).
PMID: 39008356
No abstract available.
6.
Ivanova M, Hall A, Weinberger S, Buckingham S, Copeland W, Crockett P, et al.
Child Psychiatry Hum Dev
. 2024 May;
PMID: 38796676
This randomized controlled trial tested the Family Assessment and Feedback Intervention (FAFI), a new intervention to enhance family engagement with emotional and behavioral health services. The FAFI is a guided...
7.
Wang R, Ekem L, Gallagher J, Factor R, Hall A, Ramanujam N
J Biophotonics
. 2024 Feb;
17(5):e202300241.
PMID: 38348582
We demonstrate an automated two-step tumor segmentation method leveraging color information from brightfield images of fresh core needle biopsies of breast tissue. Three different color spaces (HSV, CIELAB, YCbCr) were...
8.
Ryser M, Greenwald M, Sorribes I, King L, Hall A, Geradts J, et al.
bioRxiv
. 2023 Oct;
PMID: 37873488
Ductal carcinoma in situ (DCIS) and invasive breast cancer share many morphologic, proteomic, and genomic alterations. Yet in contrast to invasive cancer, many DCIS tumors do not progress and may...
9.
Strand S, Rivero-Gutierrez B, Houlahan K, Seoane J, King L, Risom T, et al.
Cancer Cell
. 2023 Jul;
41(7):1381.
PMID: 37433282
No abstract available.
10.
Gosling S, Arnold E, Davies S, Cross H, Bouybayoune I, Calabrese D, et al.
Sci Rep
. 2023 Jun;
13(1):9331.
PMID: 37291276
Ductal carcinoma in-situ (DCIS) accounts for 20-25% of all new breast cancer diagnoses. DCIS has an uncertain risk of progression to invasive breast cancer and a lack of predictive biomarkers...